Calendar NeuroScientific Biopharmaceuticals Limited

Equities

NSB

AU0000012973

Market Closed - Australian S.E. 02:10:05 2024-04-29 am EDT 5-day change 1st Jan Change
0.052 AUD +8.33% Intraday chart for NeuroScientific Biopharmaceuticals Limited 0.00% +18.18%

Chart calendar NeuroScientific Biopharmaceuticals Limited

e64e110e.5wP1-yzfOby1FrMMQsHCd6eat96wqVUmrkwpqQM9wgU.sjXFvW61Wvn2J8pmALK1IMbj1azi3GNK7wlO0UgNgHXVYMake6lR_sNh3A~c0850fb5608a05a06ab7fc2b3d51682a

Upcoming events on NeuroScientific Biopharmaceuticals Limited

2024-08-29 Q4 2024 Earnings Release (Projected)
2025-03-02 Q2 2025 Earnings Release (Projected)
2025-08-28 Q4 2025 Earnings Release (Projected)
2026-03-01 Q2 2026 Earnings Release (Projected)

Past events on NeuroScientific Biopharmaceuticals Limited

2024-02-27 01:43 am Q2 2024 Earnings Release
2024-01-30 05:55 pm December 2023 Sales and Revenue Release - Activities Report
2023-11-29 11:00 pm Annual General Meeting
2023-10-30 11:00 pm September 2023 Sales and Revenue Call - Activities Report
2023-10-30 12:11 am September 2023 Sales and Revenue Release - Activities Report
2023-08-25 01:30 am Q4 2023 Earnings Release
2023-07-27 08:04 pm June 2023 Sales and Revenue Release - Activities Report
2023-02-27 03:56 pm Q2 2023 Earnings Release
2023-02-02 10:00 pm December 2022 Sales and Revenue Call - Activities Report
2023-01-30 December 2022 Sales and Revenue Release - Activities Report
2022-11-24 12:00 am Annual General Meeting
2022-09-19 10:00 pm Business Update Call
2022-09-07 12:00 am Business Update Call
2022-08-29 06:02 pm FY 2022 Earnings Release
2022-07-28 June 2022 Sales and Revenue Release - Activities Report
2022-06-22 11:00 pm Gold Coast Investment Showcase
2022-04-28 March 2022 Sales and Revenue Release - Activities Report
2022-03-23 08:30 pm Broker Briefing Tech & Biotech Investor Webinar
2022-02-27 05:45 pm Interim 2022 Earnings Release
2022-01-30 07:58 pm December 2021 Sales and Revenue Release - Activities Report
  1. Stock Market
  2. Equities
  3. NSB Stock
  4. Calendar NeuroScientific Biopharmaceuticals Limited